Clinical Trials Browser

Breast Neoplasms × Bulk Drugs × Clear all

NCT06299124 2025-01-20

A Phase I Study of RGT-419B in Patients With HR-Positive, HER2-Negative Advanced Breast Cancer or Other Solid Tumors

Phase 1 Active not recruiting

Breast Neoplasms